We are delighted to add our latest Educational Series on B cell-targeting therapy for relapsing multiple sclerosis. This review article provides information on relapsing-remitting MS, B cell-depleting therapy for relapsing-remitting MS, and optimisation of timing of high-efficacy DMT for MS.
The review includes guiding commentary from Dr Mike Boggild, Director of Neurology at The Townsville Hospital.
Please login below to download this issue (PDF)